Semaglutide biosimilar (Rani Therapeutics)

N/A

Report date: 2025/03/14 18:03:15

Base Information

Drug NameSemaglutide biosimilar (Rani Therapeutics)
Drug Alias NameRT-116
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRani Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesRani Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A